Hematological and biochemical factors predicting SARS fatality in Taiwan

Journal of the Formosan Medical Association

Volumn 105, Issue 6, 2006, Pages 439-450

  Chang, Hsiao Ling ^a,b   Chen, Kow Tong ^c   Lai, Shu Kuan ^a   Kuo, Hung Wei ^a   Su, Ih Jen ^d   Lin, Ruey S ^b   Sung, Fung Chang ^b,e  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

C reactive protein; Dyspnea; Fatality; Lactic acid dehydrogenase; Lymphopenia; Respiratory syndrome; Severe acute

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE;

ADULT; AGE; AGED; ARTERIAL GAS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DYSPNEA; ERYTHROCYTE COUNT; FATALITY; FEMALE; GENDER; HEMATOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUTROPHIL COUNT; PREDICTION; PROTEIN BLOOD LEVEL; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL RATE; TAIWAN;

EID: 33745616346     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60183-2     Document Type: Article

References (41)

1. World Health Organization. Summary table of areas that experienced local transmission of SARS during the outbreak period from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/csr/sars/areas/ areas2003_11_21/en/ [Accessed: November 21, 2003.]
2. Twu SJ, Chen TJ, Chen CJ, et al. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 2003;9:718-20.
3. Centers for Disease Control and Prevention. Use of quarantine to prevent transmission of severe acute respiratory syndrome-Taiwan, 2003. MMWR 2003;52:680-3.
4. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 7 August 2003. Available at: http:// www.who.int/csr/sars/country/en/country2003_08_15.pdf [Accessed: August 15, 2003]
5. Chan JW, Ng CK, Chan YH, et al. Short-term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58:686-9.
6. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:374-80.
7. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289: 2801-9.
8. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-25.
9. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361: 1761-6.
10. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361: 1767-72.
11. Hsu LY, Lee CC, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003;9: 713-7.
12. Singh K, Hsu LY, Villacian JS, et al. Severe acute respiratory syndrome: lessons from Singapore. Emerg Infect Dis 2003; 9:1294-98.
13. Tsang OT, Chau TN, Choi KW, et al. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis 2003;9: 1381-87.
14. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977-85.
15. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
16. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986-94.
17. Chan-Yeung M, Yu WC. Outbreak of severe acute respiratory syndrome in Hong Kong special administrative region: case report. BMJ 2003;326:850-2.
18. Rainer TH, Cameron PA, Smit DV, et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ 2003;326:1354-8.
19. Fowler RA, Lapinsky SE, Hallett D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA 2003;290: 367-73.
20. Tsui PT, Kwok ML, Yuen H, et al. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003;9:1064-9.
21. Wang RSM, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326:1358-62.
22. Wang JT, Sheng WH, Fang CT, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis 2004;10:818-24.
23. World Health Organization. Case definitions for surveillance of seuere acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/ sars/casedefinition/en/ [Accessed: May 30, 2003]
24. World Health Organization. Alert, verification and public health management of SARS in the post-outbreak period. Available at: http:// www.who.int/csr/sars/postoutbreak/en/print.html [Accessed: August 14, 2003]
25. Fischbach F. A Manual of Laboratory and Diagnostic Tests, 7th edition. Philadelphia, Pa: Lippincott Williams & Wilkins, 2004.
26. World Health Organization. WHO issues consensus document on the epidemiology of SARS. Available at: http://www.who.int/csr/sars/archive/ epiconsensus/en/print.html [Accessed: October 17, 2003]
27. Antinori A, Maiuro G, Pallavicini F, et al. Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Eur J Epidemiol 1993;9:183-9.
28. Montaner JS, Hawley PH, Ronco JJ, et al. Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP. Chest 1992;102:1823-8.
29. Quist J, Hill AR. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis and bacterial pneumonia. Chest 1995;108:415-8.
30. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272:50-3.
31. Pepys MB, Baltz ML. Acute phase protein with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983;34:141-2.
32. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-43.
33. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of the first cardiovascular events. N Engl J Med 2003;347:1557-65.
34. Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290:2945-51.
35. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982;389:406-18.
36. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999;18:875-81.
37. Peltola H, Jaakkola M. C-reactive protein in early detection of bacterial versus viral infections in immunocompetent and immunocompromised children. J Pediatr 1988;113: 41-6.
38. Taina J, Jussi M, Pia T, et al. Clinical profile of serologically diagnosed pneumococcal pneumonia. Pediatr Infect Dis J 2001;20:1028-33.
39. Kawasaki Y, Hosoya M, Katayose M, et al. Correlation between serum interleukin 6 and C-reactive protein concentrations in patients with adenoviral respiratory infection. Pediatr Infect Dis J 2002;21:370-4.
40. Ruuskanen O, Meurman O, Sarkkinen H. Adenoviral diseases in children: a study of 105 hospital cases. Pediatrics 1985;76:79-83.
41. Putto A, Meurman O, Ruuskanen O. C-reactive protein in the differentiation of adenoviral, Epstein-Barr viral and streptococcal tonsillitis in children. Eur J Pediatr 1986;145: 204-6.